S59 Coordination Chemistry for Drug Discovery and Biomedical Sciences

Conference building 3F, Meeting Room 6 (August 1, Day)
Conference building 3F, Shirakashi Conference Room 2 (August 2, AM)

Date: August 1(Day),2(AM)

Professor Shin Aoki, Tokyo University of Science, Japan
Professor Takakazu Nakabayashi, Tohoku University, Japan
Professor Chris Orvig, University of British Columbia (UBC), Canada
Professor Bruno Therrien, Neuchâtel, Switzerland
Professor Milan Melnik, Slovakia, Technical University, Slovakia

Keynote Speakers

Professor Christopher Orvig, University of British Columbia (UBC), Canada Lecture title "Inorganic Radiopharmaceutical Chemistry"

Professor Milan Melnik, Slovakia Technical University, Slovakia Lecture title "Copper(II) complexes, non steroidal antirheumatic agents"

Professor Christoph J. Fahrni, Georgia Institute of Technology, USA Lecture title "Expanding the toolbox for probing cellular copper homeostasis

Professor Hideki Masuda, Nagoya Institute of Technology, Japan Lecture title "Preparation of Co(IIII) Complexes Showing Selective Binding Ability Toward Nitrogen Oxide and Its Application to DDS"

Invited Speakers

Professor Takakazu Nakabayashi
Professor Dinorah Gambino
Professor Gilles Lemercier
Associate Professor Taiho Kambe
Professor Takamitsu Kohzuma
Professor Kochiro Ishimori
Professor Shin Aoki
Professor Tamara Boltersdorf

Keywords of the session

Metal drugs, Imaging of metals, Theranostics of cancer and other diseases, Metal enzymes, Metal catalysts

Scope of the session

Metal drugs are currently used in diagnosis and treatment of many diseases and their requirement is remarkably increasing, due to the limitation of organic compound drugs and antibody drugs, in the near future. The topics of this symposium include 1) the design and synthesis of new metal drugs for diagnosis and treatment (theranostic that depicts a combination of diagnosis and treatment) of cancer, infectious diseases, neurodegenerative diseases, virus infection, and so on, 2) the development of new imaging probes (luminescence, PET, and MRI, etc).to study biological roles of intracellular metals, 3) the development of new catalyst for the efficient synthesis of drugs, 4) the development of new model compounds of metal enzymes to study their structures and functions, 5) the development of new drugs for photodynamic therapy, 6) the design and synthesis of new metal complexes and radioactive metal complexes for radiation therapy of cancer and related diseases, 7) the molecular machines that function in living systems, and so on. Contributions from the related scientific fields are welcome and we would like to offer good opportunities for the participants to enjoy attractive research topics, discussing research interests, and making valuable personal relationships with active chemists.